Cargando…
Famotidine Against SARS-CoV2: A Hope or Hype?
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mayo Foundation for Medical Education and Research
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275146/ https://www.ncbi.nlm.nih.gov/pubmed/32753153 http://dx.doi.org/10.1016/j.mayocp.2020.05.027 |
_version_ | 1783542724743397376 |
---|---|
author | Ghosh, Ritwik Chatterjee, Subhankar Dubey, Souvik Lavie, Carl J. |
author_facet | Ghosh, Ritwik Chatterjee, Subhankar Dubey, Souvik Lavie, Carl J. |
author_sort | Ghosh, Ritwik |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7275146 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Mayo Foundation for Medical Education and Research |
record_format | MEDLINE/PubMed |
spelling | pubmed-72751462020-06-08 Famotidine Against SARS-CoV2: A Hope or Hype? Ghosh, Ritwik Chatterjee, Subhankar Dubey, Souvik Lavie, Carl J. Mayo Clin Proc Article Mayo Foundation for Medical Education and Research 2020-08 2020-06-06 /pmc/articles/PMC7275146/ /pubmed/32753153 http://dx.doi.org/10.1016/j.mayocp.2020.05.027 Text en © 2020 Mayo Foundation for Medical Education and Research. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Ghosh, Ritwik Chatterjee, Subhankar Dubey, Souvik Lavie, Carl J. Famotidine Against SARS-CoV2: A Hope or Hype? |
title | Famotidine Against SARS-CoV2: A Hope or Hype? |
title_full | Famotidine Against SARS-CoV2: A Hope or Hype? |
title_fullStr | Famotidine Against SARS-CoV2: A Hope or Hype? |
title_full_unstemmed | Famotidine Against SARS-CoV2: A Hope or Hype? |
title_short | Famotidine Against SARS-CoV2: A Hope or Hype? |
title_sort | famotidine against sars-cov2: a hope or hype? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275146/ https://www.ncbi.nlm.nih.gov/pubmed/32753153 http://dx.doi.org/10.1016/j.mayocp.2020.05.027 |
work_keys_str_mv | AT ghoshritwik famotidineagainstsarscov2ahopeorhype AT chatterjeesubhankar famotidineagainstsarscov2ahopeorhype AT dubeysouvik famotidineagainstsarscov2ahopeorhype AT laviecarlj famotidineagainstsarscov2ahopeorhype |